Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03623074 · ClinicalTrials.gov registry record · NA

Control of Myopia Using Novel Spectacle Lens Designs

A NA study of Juvenile Myopia, sponsored by SightGlass Vision.

Active
Registry status
NA
Development phase
266
Enrollment target
14
Study locations

NCT03623074 is a NA study of Juvenile Myopia that is active but no longer recruiting, run by SightGlass Vision. The registered enrollment target is 266 participants, above the 94-participant average among 6 other Juvenile Myopia trials with a reported enrollment target (183% higher). The trial reports 14 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03623074, a NA study of Juvenile Myopia, is active but no longer recruiting, sponsored by SightGlass Vision.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
266 participants
Enrollment target
14
Study locations

Study Summary

Randomized, controlled, multisite, subject-and observer-masked, 3-arm parallel group clinical trial of 36-month duration to evaluate the safety and efficacy of a novel spectacle lens design in reducing the progression of juvenile myopia.

Conditions Studied

Juvenile Myopia

Interventions

  • DEVICE Novel spectacle lens design
  • DEVICE Spectacle lenses

Study Locations (14)

New York

  • SUNY School of Optometry - New York
  • Sacco Eye Group - Vestal
  • Dept of Clinical Research, South Shore Eye Care, LLP - Wantagh

Florida

  • Sabal Eye Care - Longwood
  • Visual Performance Center - Pensacola

California

  • Golden Optometric Group - Whittier

Kansas

  • Kannarr Eye Care - Pittsburg

Louisiana

  • Eye Associates of Northeast Louisiana (DBA Haik Humble Eye Center) Research Dept - West Monroe

Missouri

  • Advanced Eyecare, PC - Raytown

South Dakota

  • Dunes Eye Consultants - Dakota Dunes

Tennessee

  • Total Eye Care - Memphis

Trial Details

FieldValue
Enrollment Target 266 participants
Start Date 2018-07-16
Est. Completion 2026-03-31
Phase NA

Sponsor

SightGlass Vision

8 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03623074

The ClinicalTrials.gov registry entry for NCT03623074 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 266 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 94-participant average among 6 other Juvenile Myopia trials with a reported enrollment target (183% higher). The listed sponsor is SightGlass Vision, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Juvenile Myopia appearing as the primary indexed condition, and to 2 interventions - of which Novel spectacle lens design is the first listed.

NCT03623074 reports 14 study locations spanning 11 distinct geographic areas - top geographies include New York, Florida, California.

Frequently Asked Questions

What is clinical trial NCT03623074 about?

NCT03623074 is a clinical study titled "Control of Myopia Using Novel Spectacle Lens Designs". Randomized, controlled, multisite, subject-and observer-masked, 3-arm parallel group clinical trial of 36-month duration to evaluate the safety and efficacy of a novel spectacle lens design in reducing the progression of juvenile myopia.

What is the current status of trial NCT03623074?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 266 participants. The study started on 2018-07-16. Estimated completion is 2026-03-31.

What conditions does trial NCT03623074 study?

This clinical trial studies the following conditions: Juvenile Myopia.

What interventions are being tested in trial NCT03623074?

The interventions under investigation include: Novel spectacle lens design (DEVICE), Spectacle lenses (DEVICE).

Who is sponsoring clinical trial NCT03623074?

This trial is sponsored by SightGlass Vision, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03623074 being conducted?

This trial has 14 study locations across California, Florida, Kansas, Louisiana, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Juvenile Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Juvenile Myopia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.